Literature DB >> 22492317

Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey.

Christine Selton-Suty1, Marie Célard, Vincent Le Moing, Thanh Doco-Lecompte, Catherine Chirouze, Bernard Iung, Christophe Strady, Matthieu Revest, François Vandenesch, Anne Bouvet, François Delahaye, François Alla, Xavier Duval, Bruno Hoen.   

Abstract

BACKGROUND: Observational studies showed that the profile of infective endocarditis (IE) significantly changed over the past decades. However, most studies involved referral centers. We conducted a population-based study to control for this referral bias. The objective was to update the description of characteristics of IE in France and to compare the profile of community-acquired versus healthcare-associated IE.
METHODS: A prospective population-based observational study conducted in all medical facilities from 7 French regions (32% of French individuals aged ≥18 years) identified 497 adults with Duke-Li-definite IE who were first admitted to the hospital in 2008. Main measures included age-standardized and sex-standardized incidence of IE and multivariate Cox regression analysis for risk factors of in-hospital death.
RESULTS: The age-standardized and sex-standardized annual incidence of IE was 33.8 (95% confidence interval [CI], 30.8-36.9) cases per million inhabitants. The incidence was highest in men aged 75-79 years. A majority of patients had no previously known heart disease. Staphylococci were the most common causal agents, accounting for 36.2% of cases (Staphylococcus aureus, 26.6%; coagulase-negative staphylococci, 9.7%). Healthcare-associated IE represented 26.7% of all cases and exhibited a clinical pattern significantly different from that of community-acquired IE. S. aureus as the causal agent of IE was the most important factor associated with in-hospital death in community-acquired IE (hazard ratio [HR], 2.82 [95% CI, 1.72-4.61]) and the single factor in healthcare-associated IE (HR, 2.54 [95% CI, 1.33-4.85]).
CONCLUSIONS: S. aureus became both the leading cause and the most important prognostic factor of IE, and healthcare-associated IE appeared as a major subgroup of the disease.

Entities:  

Mesh:

Year:  2012        PMID: 22492317     DOI: 10.1093/cid/cis199

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  148 in total

Review 1.  The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century.

Authors:  J Ambrosioni; M Hernandez-Meneses; A Téllez; J Pericàs; C Falces; J M Tolosana; B Vidal; M Almela; E Quintana; J Llopis; A Moreno; José M Miro
Journal:  Curr Infect Dis Rep       Date:  2017-05       Impact factor: 3.725

2.  Infective Endocarditis in French West Indies: A 13-Year Observational Study.

Authors:  Elisabeth Fernandes; Claude Olive; Jocelyn Inamo; François Roques; André Cabié; Patrick Hochedez
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

3.  Optimal timing for cardiac surgery in infective endocarditis: is earlier better?

Authors:  François Delahaye; Anne-Marie Antchouey; Guy de Gevigney
Journal:  Curr Infect Dis Rep       Date:  2014-07       Impact factor: 3.725

4.  Native Triple Valve Endocarditis as Complication of Post-Abortal Sepsis.

Authors:  Mohan Venkata Sumedha Maturu; Tom Devasia; Mugula Sudhakar Rao; Hashir Kareem
Journal:  J Clin Diagn Res       Date:  2016-07-01

5.  Prosthetic valve endocarditis due to Propionibacterium acnes.

Authors:  Richard van Valen; Robert A F de Lind van Wijngaarden; Nelianne J Verkaik; Mostafa M Mokhles; Ad J J C Bogers
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-04-06

6.  Prospective comparison of infective endocarditis in Khon Kaen, Thailand and Rennes, France.

Authors:  George Watt; Adele Lacroix; Orathai Pachirat; Henry C Baggett; Didier Raoult; Pierre-Edouard Fournier; Pierre Tattevin
Journal:  Am J Trop Med Hyg       Date:  2015-02-02       Impact factor: 2.345

Review 7.  The use of allogenic and autologous tissue to treat aortic valve endocarditis.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Mario Lusini; Antonio Nenna; Ivancarmine Gambardella; Massimo Chello
Journal:  Ann Transl Med       Date:  2019-09

8.  Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN.

Authors:  Daniel C DeSimone; Imad M Tleyjeh; Daniel D Correa de Sa; Nandan S Anavekar; Brian D Lahr; Muhammad R Sohail; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Am Heart J       Date:  2015-07-17       Impact factor: 4.749

9.  Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection.

Authors:  Michael R Yeaman; Scott G Filler; Siyang Chaili; Kevin Barr; Huiyuan Wang; Deborah Kupferwasser; John P Hennessey; Yue Fu; Clint S Schmidt; John E Edwards; Yan Q Xiong; Ashraf S Ibrahim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

10.  Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals.

Authors:  P V Damasco; J N Ramos; J C D Correal; M V Potsch; V V Vieira; T C F Camello; M P Pereira; V D Marques; K R N Santos; E A Marques; M B Castier; R Hirata; A L Mattos-Guaraldi; C Q Fortes
Journal:  Infection       Date:  2014-06-17       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.